High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer

被引:130
作者
Emerson, Ryan O. [1 ]
Sherwood, Anna M. [1 ]
Rieder, Mark J. [1 ]
Guenthoer, Jamie [2 ]
Williamson, David W. [1 ]
Carlson, Christopher S. [2 ]
Drescher, Charles W. [2 ,3 ]
Tewari, Muneesh [2 ,3 ]
Bielas, Jason H. [2 ]
Robins, Harlan S. [2 ]
机构
[1] Adapt Biotechnol, Seattle, WA USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Sch Med, Seattle, WA USA
关键词
T cells; high-throughput sequencing; tumour-infiltrating lymphocytes (TILs); tumour heterogeneity; ovarian carcinoma; HETEROGENEITY; IMMUNOTHERAPY; RESISTANCE; MUTATIONS; PROGNOSIS; STAGE; TOOL;
D O I
10.1002/path.4260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cellular adaptive immune system mounts a response to many solid tumours mediated by tumour-infiltrating T lymphocytes (TILs). Basic measurements of these TILs, including total count, show promise as prognostic markers for a variety of cancers, including ovarian and colorectal. In addition, recent therapeutic advances are thought to exploit this immune response to effectively fight melanoma, with promising studies showing efficacy in additional cancers. However, many of the basic properties of TILs are poorly understood, including specificity, clonality, and spatial heterogeneity of the T-cell response. We utilize deep sequencing of rearranged T-cell receptor beta (TCRB) genes to characterize the basic properties of TILs in ovarian carcinoma. Due to somatic rearrangement during T-cell development, the TCR beta chain sequence serves as a molecular tag for each T-cell clone. Using these sequence tags, we assess similarities and differences between infiltrating T cells in discretely sampled sections of large tumours and compare to T cells from peripheral blood. Within the limits of sensitivity of our assay, the TIL repertoires show strong similarity throughout each tumour and are distinct from the circulating T-cell repertoire. We conclude that the cellular adaptive immune response within ovarian carcinomas is spatially homogeneous and distinct from the T-cell compartment of peripheral blood. Copyright (c) 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 32 条
[1]   Evolutionary foundations for cancer biology [J].
Aktipis, C. Athena ;
Nesse, Randolph M. .
EVOLUTIONARY APPLICATIONS, 2013, 6 (01) :144-159
[2]   The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment [J].
Ascierto, Paolo A. ;
Capone, Mariaelena ;
Urba, Walter J. ;
Bifulco, Carlo B. ;
Botti, Gerardo ;
Lugli, Alessandro ;
Marincola, Francesco M. ;
Ciliberto, Gennaro ;
Galon, Jerome ;
Fox, Bernard A. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[3]   Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types [J].
Ascierto, Paolo A. ;
Kalos, Michael ;
Schaer, David A. ;
Callahan, Margaret K. ;
Wolchok, Jedd D. .
CLINICAL CANCER RESEARCH, 2013, 19 (05) :1009-1020
[4]   Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss [J].
Clarke, Blaise ;
Tinker, Anna V. ;
Lee, Cheng-Han ;
Subramanian, Subbaya ;
van de Rijn, Matt ;
Turbin, Dmitry ;
Kalloger, Steve ;
Han, Guangming ;
Ceballos, Kathy ;
Cadungog, Mark G. ;
Huntsman, David G. ;
Coukos, George ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :393-402
[5]   T-CELL ANTIGEN RECEPTOR GENES AND T-CELL RECOGNITION [J].
DAVIS, MM ;
BJORKMAN, PJ .
NATURE, 1988, 334 (6181) :395-402
[6]   Cancer and Immune Response: Old and New Evidence for Future Challenges [J].
de la Cruz-Merino, Luis ;
Grande-Pulido, Enrique ;
Albero-Tamarit, Ana ;
Codes-Manuel de Villena, Manuel Eduardo .
ONCOLOGIST, 2008, 13 (12) :1246-1254
[7]   Cancer heterogeneity: implications for targeted therapeutics [J].
Fisher, R. ;
Pusztai, L. ;
Swanton, C. .
BRITISH JOURNAL OF CANCER, 2013, 108 (03) :479-485
[8]   The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures [J].
Galon, Jerome ;
Angell, Helen K. ;
Bedognetti, Davide ;
Marincola, Francesco M. .
IMMUNITY, 2013, 39 (01) :11-26
[9]   The Immune Score as a New Possible Approach for the Classification of Cancer [J].
Galon, Jerome ;
Pages, Franck ;
Marincola, Francesco M. ;
Thurin, Magdalena ;
Trinchieri, Giorgio ;
Fox, Bernard A. ;
Gajewski, Thomas F. ;
Ascierto, Paolo A. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
[10]   Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization [J].
Gavalas, Nikos G. ;
Karadimou, Alexandra ;
Dimopoulos, Meletios A. ;
Bamias, Aristotelis .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,